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Background
There is an increasing recognition that Neurological dis-
eases, both chronic and disabling, are effected by multi-
ple domains. It is crucial to select outcome measures
and their rating scales to assess the meaningful results
of a clinical study. The aim of the study is to address
the mismatch between what clinical researchers do and
what patients need.
Methods
Stroke, dementia and epilepsy are the greater and most
common disabling neurological diseases and were con-
sidered in this study. For each mentioned disease we
will perform a Systematic reviews of all randomized
clinical trials published in any language over the last
5 years with the aim of identifying and analyzing the
outcome measures used in the evaluation of any kind of
intervention. Fifteen Neurologists are filling out a single
computerized form for each single trial assigned.
The form has the following information: Characteris-
tics of the trial with relevance on quality, Extent of varia-
bility in end points selected and their domains, Scales or
techniques used to make the measurement, type of analy-
sis applied and time of measurement, Presence of attrition
bias in terms of fraction of patients reported by end
points on the number enrolled in the study, Presence of
outcome reporting bias in terms of end points declared
and non-reported, end points not declared but reported,
Source of funding.
The valuation of patient and career needs and emo-
tions will be performed with focus group discussions in
a parallel section of the study.
Results
We start to offer a photograph of recent research on Epi-
lepsy. We searched electronic databases, the Cochrane
Central Register of Controlled Trials (CENTRAL) and
MEDLINE, as well as ongoing trial registries, from
1.01.2009 to 31.12.2013. We have examined 949 papers
published (see trials flow diagram in Figure 1). Only
17.6% are randomized clinical trials while another 18% of
these fail to reach the target on proven efficacy of evalu-
ated treatment.
Conclusions
This result gives a first indication of how valuable
resources are wasted. More importantly we are consider-
ing the weaknesses in the design, analysis and conflicts of
interest in the included 17.6% of RCTs, highlighting
research that should be better directed.
This approach could provide useful information to clini-
cians, who will have an opportunity to learn how to use a
new framework in the production, reporting and critical
appraisal of literature and it could also help to bridge the
gap between end-users and investigators and promote
valuable clinical research.
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Figure 1 Trial flow diagram
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